Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11230589 Fusion molecules and uses thereof

Patent 11230589 was granted and assigned to Foundation Medicine on January, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Foundation Medicine

Current Assignee

Foundation Medicine

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

112305890

Patent Inventor Names

Roman Yelensky0

Doron Lipson0

Jie He0

Joel Robert Greenbowe0

Date of Patent

January 25, 2022

Patent Application Number

144405690

Date Filed

November 5, 2013

Patent Citations

‌

US Patent 10000814 ALK and NTRK1 fusion molecules and uses thereof

Patent Citations Received

‌

US Patent 11578372 NTRK1 fusion molecules and uses thereof

‌

US Patent 11771698 Methods of treating cholangiocarcinoma

Patent Primary Examiner

‌

Juliet C. Switzer

Patent abstract

Novel fusion molecules and uses are disclosed.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11230589 Fusion molecules and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API